2Hiceto S, Scrutinio D, Bruzzi P, et al. On behalf of the CEDIM investigalors. Firects of L - carnitine administration on left ventricular remodeling after acute anterior myocardial infarction: the L - camitine echocardiografia digitalizata infarctomiocardico(CEDIM)[J]. J Am Coll Cardiol. 1995.26:380 - 387.
3Calvani M, Reda E, Arrigoni - Martelli E. Regulation by camitine of myocardial fatty acid and carbohydrate metabolism under normal and pathological conditions [J]. Basic Res Cardiol,2000.95(2):75- 83.
4梅长林，中华肾脏病杂志，1998年，12卷
5Rebouche CJ, Paulson DJ. Carnitine metabolism and function in humans. Ann Rev Nutr, 1986,6: 41-66.
6Rebouche CJ, Seim H. Carnitine metabolism and its regulation in microorganisms and mammals. Ann Rev Nutr, 1998,18:39 61.
7Bellinghieri G, Santoro D, Calvani M, et al. Carnitine and hemodialysis. Am J Kidney Dis, 2003,41 (3 suppl 1 ): S116-S122.
8Evans A. Dialysis-related carnitine disorder and levocarnitine pharmacology. Am J Kidney Dis,2003,41(4 suppl 4) :S13-S26.
9Evans AM, Faull R, Fornasini G, et al. Pharmacokinetics of Lcarnitine in patients with end-stage renal disease undergoing long term hemodialysis. Clin Pharmacol Ther, 2000,68:238-249.
10Brass EP, Adler S, Sietsema KE, et al. Intravenous L-carnitineincreases plasma carnitine, reduces fatigue, and may preserve exercise capacity in hemodialysis patients. Am J Kidney Dis, 2001,37:1018-1028.
